TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 12679392

Group type: EXPERIMENTAL
Intervention: CBF SPECT with 3D fractal analysis (3D-FA) and 3D stereotactic surface projections (3D-SSP)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: 3D-SSP analysis
Number of subjects: 17

Group type: COMPARATOR
Intervention: Control group (healthy volunteers)
Number of subjects: 17
Study: 10919684

Group type: EXPERIMENTAL
Intervention: HFA 134a pMDI
Number of subjects: 412

Group type: COMPARATOR
Intervention: CFC pMDI
Number of subjects: 412
Study: 8904627

Group type: EXPERIMENTAL
Intervention: 1 mg butorphanol nasal spray every 6 h
Number of subjects: 16

Group type: COMPARATOR
Intervention: 300 mg cimetidine tablet every 6 h
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Combination of butorphanol nasal spray and cimetidine every 6 h
Number of subjects: 16
Study: 1414906

Group type: EXPERIMENTAL
Intervention: 240 mg SR verapamil with a standardized meal
Number of subjects: 9

Group type: COMPARATOR
Intervention: 240 mg SR verapamil on an empty stomach
Number of subjects: 9

Group type: COMPARATOR
Intervention: 10 mg intravenous verapamil
Number of subjects: 9
Study: 4064556

Group type: EXPERIMENTAL
Intervention: Linear visual analogue scaling
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ratio magnitude estimation
Number of subjects: 0
Study: 31680077

Group type: EXPERIMENTAL
Intervention: 2% FV diet
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 4% FV diet
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control diet
Number of subjects: 30
Study: 30137647

Group type: EXPERIMENTAL
Intervention: Vitamin D3 400 IU/day
Number of subjects: 194

Group type: EXPERIMENTAL
Intervention: Vitamin D3 800 IU/day
Number of subjects: 194

Group type: EXPERIMENTAL
Intervention: Vitamin D3 1600 IU/day
Number of subjects: 194

Group type: EXPERIMENTAL
Intervention: Vitamin D3 2400 IU/day
Number of subjects: 194

Group type: EXPERIMENTAL
Intervention: Vitamin D3 3200 IU/day
Number of subjects: 194

Group type: EXPERIMENTAL
Intervention: Vitamin D3 4000 IU/day
Number of subjects: 194

Group type: EXPERIMENTAL
Intervention: Vitamin D3 4800 IU/day
Number of subjects: 194

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 194
Study: 27903247

Group type: EXPERIMENTAL
Intervention: Conventional chemoradiotherapy (CRT)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Short-term radiotherapy (RT)
Number of subjects: 150
Study: 25271117

Group type: EXPERIMENTAL
Intervention: retrospective continuous glucose monitoring (r-CGM)
Number of subjects: 92

Group type: COMPARATOR
Intervention: self-monitoring of blood glucose (SMBG)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Insulin initiation and titration
Number of subjects: 92
Study: 22541308

Group type: EXPERIMENTAL
Intervention: Intense rehabilitation therapies with acupuncture (5 times per week for 12 weeks)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Intense rehabilitation therapies without acupuncture (5 times per week for 12 weeks)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Acupuncture added to rehabilitation therapies (weeks 16-28)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Combined groups after intense therapies
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Children with GMFCS II level
Number of subjects: 75
Study: 20547926

Group type: EXPERIMENTAL
Intervention: Higher collateral grade
Number of subjects: 2173

Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention
Number of subjects: 2173

Group type: COMPARATOR
Intervention: Medical therapy alone
Number of subjects: 2173
Study: 19011792

Group type: EXPERIMENTAL
Intervention: 50% N2O + 50% O2
Number of subjects: 80

Group type: COMPARATOR
Intervention: Room air
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 80
Study: 15632815

Group type: EXPERIMENTAL
Intervention: Flexible diuretic titration (DT)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 66
Study: 11854636

Group type: EXPERIMENTAL
Intervention: Gestational diabetes mellitus
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Single abnormal glucose tolerance test value
Number of subjects: 110

Group type: COMPARATOR
Intervention: Normal oral glucose tolerance test results
Number of subjects: 110
Study: 10188899

Group type: EXPERIMENTAL
Intervention: Pre-operative chemotherapy (mitomycin-C 8 mg m(‐2), vinblastine 6 mg m(‐2), cisplatin 50 mg m(‐2) - MVP) followed by surgery
Number of subjects: 22

Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 22
Study: 7564895

Group type: EXPERIMENTAL
Intervention: Hexyl nicotinate (HN) 0.5% ethanol solution
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Methyl nicotinate (MN) 5% ethanol solution
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Both HN and MN
Number of subjects: 16
Study: 2250114

Group type: EXPERIMENTAL
Intervention: Combined heat and radiation therapy (thermoradiotherapy)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control group (only irradiated)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Thermoradiotherapy
Number of subjects: 56
Study: 6985998

Group type: EXPERIMENTAL
Intervention: 1 g of aspirin per day
Number of subjects: 4524

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4524
Study: 30859961

Group type: EXPERIMENTAL
Intervention: Amphetamine extended-release oral suspension (AMPH EROS)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 28981764

Group type: EXPERIMENTAL
Intervention: Community Health Worker (CHW) antenatal and postnatal home visits (average of 4.1 visits per mother)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Community Health Worker (CHW) antenatal and postnatal home visits
Number of subjects: 15
Study: 26470906

Group type: EXPERIMENTAL
Intervention: Trauma-Focused Cognitive-Behavioral Therapy (TF-CBT)
Number of subjects: 107
Study: 22814294

Group type: EXPERIMENTAL
Intervention: NOTCH1±FBXW7(Double)
Number of subjects: 162

Group type: COMPARATOR
Intervention: NOTCH1(WT)FBXW7(WT)
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: NOTCH1(Single)FBXW7(WT)
Number of subjects: 162
Study: 22201703

Group type: EXPERIMENTAL
Intervention: Web-based program for problem drinkers
Number of subjects: 156
Study: 19236279

Group type: EXPERIMENTAL
Intervention: HPV-6/11/16/18 vaccine
Number of subjects: 17622
Study: 16062012

Group type: EXPERIMENTAL
Intervention: High-impact and/or weight-bearing exercise
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Exercise
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Smoking cessation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study: 12362098

Group type: EXPERIMENTAL
Intervention: Patients with appendicitis
Number of subjects: 30

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 30
Study: 10435372

Group type: EXPERIMENTAL
Intervention: 99mTc tetrofosmin gated SPECT
Number of subjects: 17

Group type: COMPARATOR
Intervention: 18F FDG PET
Number of subjects: 17
Study: 8771219

Group type: EXPERIMENTAL
Intervention: Combined cognitive-behavioral/psychopharmacological treatment (nortriptyline or fluoxetine in AN-R, fluoxetine or amineptine in AN-BP)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Fluoxetine treatment in AN-R patients
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Fluoxetine or amineptine treatment in AN-BP patients
Number of subjects: 80

Group type: COMPARATOR
Intervention: Healthy volunteers (control group)
Number of subjects: 80
Study: 2251437

Group type: EXPERIMENTAL
Intervention: Salbutamol (100 mcg, 2 puffs)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Oxitropium bromide (100 mcg, 2 puffs)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Combination of Salbutamol and Oxitropium bromide
Number of subjects: 20
Study: 6109480

Group type: EXPERIMENTAL
Intervention: Group A - BCAA solution with 12 g N (852 mmol) and 41.1% BCAA
Number of subjects: 20

Group type: COMPARATOR
Intervention: Group B - Control solution with 18 g N (1278 mmol) and 21.1% BCAA
Number of subjects: 20
Study: 31965140

Group type: EXPERIMENTAL
Intervention: Higher egg intake (≥7 egg/wk)
Number of subjects: 177000
Study: 31354159

Group type: EXPERIMENTAL
Intervention: Crosier-shaped catheter technique
Number of subjects: 218

Group type: COMPARATOR
Intervention: Straight catheter technique
Number of subjects: 218
Study: 28114265

Group type: EXPERIMENTAL
Intervention: NSAIDs (ketorolac tromethamine 10 mg, 2 tablets daily for 2 days and amoxicillin 500 mg, 3 tablets daily for 7 days) + corticosteroids (betamethasone 2 mL injection within 10 hours after surgery)
Number of subjects: 30

Group type: COMPARATOR
Intervention: NSAIDs (ketorolac tromethamine 10 mg, 2 tablets daily for 2 days and amoxicillin 500 mg, 3 tablets daily for 7 days)
Number of subjects: 30
Study: 25894843

Group type: EXPERIMENTAL
Intervention: Homotaurine 100 mg
Number of subjects: 47

Group type: COMPARATOR
Intervention: Control group (no homotaurine)
Number of subjects: 47
Study: 24359285

Group type: EXPERIMENTAL
Intervention: Program SI! intervention
Number of subjects: 2062
Study: 21831931

Group type: EXPERIMENTAL
Intervention: Reinforced tension line (RTL) suture closure
Number of subjects: 190

Group type: COMPARATOR
Intervention: Continuous suturing
Number of subjects: 190
Study: 19473833

Group type: EXPERIMENTAL
Intervention: Cisplatin plus pemetrexed (500 mg/m2 pemetrexed IV followed by 75 mg/m2 cisplatin IV on day 1)
Number of subjects: 1669

Group type: EXPERIMENTAL
Intervention: Cisplatin plus pemetrexed
Number of subjects: 1669

Group type: COMPARATOR
Intervention: Cisplatin plus gemcitabine (1250 mg/m2 on days 1 and 8 and 75 mg/m2 cisplatin on day 1)
Number of subjects: 1669
Study: 17905807

Group type: EXPERIMENTAL
Intervention: Sibling number in the household
Number of subjects: 3928

Group type: EXPERIMENTAL
Intervention: Birth order
Number of subjects: 3928
Study: 15106069

Group type: EXPERIMENTAL
Intervention: Direct transosseous refixation
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Local tendon shifts
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Deltoid flaps
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Reconstruction with intact tendons
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Reconstruction with re-tear
Number of subjects: 38
Study: 11800185

Group type: EXPERIMENTAL
Intervention: Daily brief preference assessments
Number of subjects: 5

Group type: COMPARATOR
Intervention: Lengthy paired-choice preference assessments
Number of subjects: 5
Study: 9740601

Group type: EXPERIMENTAL
Intervention: Sodium reduction
Number of subjects: 1509

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1509

Group type: EXPERIMENTAL
Intervention: Weight loss
Number of subjects: 1509
Study: 7979291

Group type: EXPERIMENTAL
Intervention: Dapsone 200 mg weekly
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Dapsone 200 mg plus pyrimethamine 25 mg weekly
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Dapsone 200 mg plus pyrimethamine 75 mg weekly
Number of subjects: 52
Study: 2657024

Group type: EXPERIMENTAL
Intervention: Enamelbond, Heliobond, and Scotchbond
Number of subjects: 350

Group type: EXPERIMENTAL
Intervention: Dentin‐Adhesit and Scotchbond
Number of subjects: 350

Group type: EXPERIMENTAL
Intervention: P10/Dentin‐Adhesit and Silar/Scotchbond
Number of subjects: 350
Study: 31292959

Group type: EXPERIMENTAL
Intervention: Novel meat product with apple fiber (0.15%), rice starch (0.30%), and citric acid (0.16 M)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (traditional beef product)
Number of subjects: 0
Study: 29194698

Group type: EXPERIMENTAL
Intervention: Rivaroxaban 20 mg oral dose with verapamil
Number of subjects: 0
Study: 28829876

Group type: EXPERIMENTAL
Intervention: NT-proBNP-guided strategy (n=446)
Number of subjects: 894

Group type: COMPARATOR
Intervention: Usual care (n=448)
Number of subjects: 894
Study: 26161426

Group type: EXPERIMENTAL
Intervention: Pentax-AWS (AWS)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Glidescope (GVL)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Macintosh Laryngoscope (MCL)
Number of subjects: 19
Study: 22836861

Group type: EXPERIMENTAL
Intervention: Early oral refeeding (EORF)
Number of subjects: 149

Group type: COMPARATOR
Intervention: Routine oral refeeding (RORF)
Number of subjects: 149
Study: 20947072

Group type: EXPERIMENTAL
Intervention: Transvaginal three-dimensional ultrasonography and power Doppler angiography
Number of subjects: 134
Study: 18551287

Group type: EXPERIMENTAL
Intervention: Combination of T1-weighted images (T1WI), T2-weighted images (T2WI), and fluid-attenuated inversion recovery (FLAIR) images
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Combination of T1WI and FLAIR images
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Combination of T2WI and FLAIR images
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Combination of T1WI and T2WI images
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Combination of T1WI, T2WI, and FLAIR images
Number of subjects: 45
Study: 14745057

Group type: EXPERIMENTAL
Intervention: Lidocaine 5 mg/kg IV during 30 minutes
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Mexiletine titrated from 400 to 1,000 mg per day (mean 737 mg/day)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 11252361

Group type: EXPERIMENTAL
Intervention: Thermoradiotherapy (TRT)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Radiotherapy (RT)
Number of subjects: 40
Study: 9852694

Group type: COMPARATOR
Intervention: propofol 2.5 mg.kg‐1
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: pentazocine 0.3 mg.kg‐1 followed by thiamylal 5 mg.kg‐1
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: pentazocine 0.6 mg.kg‐1 followed by thiamylal 5 mg.kg‐1
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: thiamylal 5 mg.kg‐1
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: pentazocine groups
Number of subjects: 94

Group type: COMPARATOR
Intervention: propofol
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: all groups
Number of subjects: 94
Study: 8208390

Group type: EXPERIMENTAL
Intervention: Phentolamine (35 mg)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Phenylephrine (500 micrograms)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 100
Study: 2927132

Group type: EXPERIMENTAL
Intervention: Ethanol (0.7 g/kg, p.o.)
Number of subjects: 1

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1
Study: 30343415

Group type: EXPERIMENTAL
Intervention: Right groin incision with adipocutaneous flap
Number of subjects: 100

Group type: COMPARATOR
Intervention: McBurney's incision
Number of subjects: 100
Study: 27501650

Group type: EXPERIMENTAL
Intervention: 30-mL normal saline bolus
Number of subjects: 46

Group type: COMPARATOR
Intervention: Sham (control)
Number of subjects: 46
Study: 24848178

Group type: EXPERIMENTAL
Intervention: Spinal anesthesia
Number of subjects: 66

Group type: COMPARATOR
Intervention: General anesthesia
Number of subjects: 66
Study: 22554751

Group type: EXPERIMENTAL
Intervention: Etching with 30% phosphoric acid for 15 seconds with daily brushing
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Etching with 30% phosphoric acid for 15 seconds with no brushing
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Etching with 30% phosphoric acid for 30 seconds with daily brushing
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Etching with 30% phosphoric acid for 30 seconds with no brushing
Number of subjects: 90

Group type: COMPARATOR
Intervention: Non-etched control with daily brushing
Number of subjects: 90

Group type: COMPARATOR
Intervention: Non-etched control with no brushing
Number of subjects: 90
Study: 21322301

Group type: EXPERIMENTAL
Intervention: ARI Quality Dashboard
Number of subjects: 258

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 258
Study: 18852529

Group type: EXPERIMENTAL
Intervention: 5 g/d glycine
Number of subjects: 74

Group type: COMPARATOR
Intervention: 5 g/d placebo
Number of subjects: 74
Study: 15838160

Group type: EXPERIMENTAL
Intervention: Pulsatile perfusion
Number of subjects: 40

Group type: COMPARATOR
Intervention: Continuous flow
Number of subjects: 40
Study: 11262783

Group type: EXPERIMENTAL
Intervention: Recombinant human erythropoietin (300 U/kg twice a week)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Recombinant human erythropoietin (300 U/kg twice a week) and preoperative autologous blood donation
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Autologous blood administration without concurrent erythropoietin
Number of subjects: 40
Study: 9916899

Group type: EXPERIMENTAL
Intervention: Imipenem
Number of subjects: 0

Group type: COMPARATOR
Intervention: Targeted therapy
Number of subjects: 0
Study: 8063348

Group type: EXPERIMENTAL
Intervention: Isotonic training (5BX programme)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Isometric training (a programme of isometric exercises)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no specific workout)
Number of subjects: 0
Study: 3377382

Group type: EXPERIMENTAL
Intervention: Pilocarpine 4% gel
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pilocarpine 4% solution
Number of subjects: 0
Study: 31136659

Group type: EXPERIMENTAL
Intervention: 1 cup of blueberries per day
Number of subjects: 115

Group type: COMPARATOR
Intervention: 1/2 cup of blueberries per day
Number of subjects: 115

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 115
Study: 28432266

Group type: EXPERIMENTAL
Intervention: Intra-Arterial Treatment (IAT)
Number of subjects: 0
Study: 25369890

Group type: EXPERIMENTAL
Intervention: Calcifediol (20 μg per day)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Vitamin D3 (20 μg or 800 IU per day)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Calcifediol
Number of subjects: 20

Group type: COMPARATOR
Intervention: Vitamin D3
Number of subjects: 20
Study: 23289005

Group type: EXPERIMENTAL
Intervention: Percutaneous adhesiolysis with caudal epidural injections, including 5 mL of 2% preservative-free lidocaine, 6 mL of 10% hypertonic sodium chloride solution, and 6 mg of non-particulate betamethasone.
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Percutaneous adhesiolysis
Number of subjects: 70
Study: 22321500

Group type: EXPERIMENTAL
Intervention: MICS group (coaxial 1.8 mm microincision cataract surgery)
Number of subjects: 89

Group type: COMPARATOR
Intervention: SICS group (coaxial 3 mm small-incision cataract surgery)
Number of subjects: 89
Study: 19212794

Group type: EXPERIMENTAL
Intervention: Reflux events in patients with primary respiratory symptoms (RS)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Reflux events in patients with primary esophageal symptoms (ES)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Proximal reflux events in patients with primary respiratory symptoms (RS)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Proximal reflux events in patients with primary esophageal symptoms (ES)
Number of subjects: 30
Study: 16455222

Group type: EXPERIMENTAL
Intervention: Lifestyle physical activity counseling program with feedback of a pedometer during pulmonary rehabilitation
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control group (only followed rehabilitation)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Experimental group
Number of subjects: 21
Study: 15315996

Group type: EXPERIMENTAL
Intervention: 3D-CRT plus 6 months of AST
Number of subjects: 206

Group type: COMPARATOR
Intervention: 3D-CRT alone
Number of subjects: 206
Study: 11344343

Group type: EXPERIMENTAL
Intervention: Salmeterol plus low-dose fluticasone (42 microg of salmeterol and 88 microg of FP)
Number of subjects: 925

Group type: COMPARATOR
Intervention: Higher-dose fluticasone (220 microg)
Number of subjects: 925

Group type: EXPERIMENTAL
Intervention: Salmeterol plus low-dose FP
Number of subjects: 925
Study: 9022580

Group type: EXPERIMENTAL
Intervention: T1-weighted axial and coronal images with an axial FSE T2-weighted sequence
Number of subjects: 0

Group type: COMPARATOR
Intervention: Enhanced T1 fat suppressed sequence
Number of subjects: 0
Study: 7937520

Group type: EXPERIMENTAL
Intervention: R(−)ibuprofen (intravenously infused as a racemic mixture)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: R(−)ibuprofen (intravenously infused alone)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: S(+)ibuprofen (dosed as S(+)ibuprofen)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: R(−)ibuprofen (concurrent administration with S(+)ibuprofen)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: R(−)ibuprofen (intravenous dose)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: R(−)ibuprofen lysinate (oral dose)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: S(+)ibuprofen
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: R(−)ibuprofen (dosed alone)
Number of subjects: 12
Study: 29471679

Group type: EXPERIMENTAL
Intervention: 70 mg erenumab
Number of subjects: 577

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 577
Study: 27103412

Group type: EXPERIMENTAL
Intervention: Partnered conditions (partner‐ingroup and partner‐outgroup)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Partner‐ingroup ('Us')
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Partner‐outgroup ('Them')
Number of subjects: 96
Study: 25071111

Group type: COMPARATOR
Intervention: Patient navigation (navigated participants) for antiestrogen therapy
Number of subjects: 761

Group type: COMPARATOR
Intervention: Patient navigation (navigated participants) for radiation therapy
Number of subjects: 761
Study: 22215243

Group type: EXPERIMENTAL
Intervention: Laparoscopic paraesophageal hernia repair (LPEHR)
Number of subjects: 108
Study: 20113387

Group type: EXPERIMENTAL
Intervention: Red grape juice
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Red grape juice plus alcohol (12% v/v)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Water
Number of subjects: 10
Study: 18204347

Group type: EXPERIMENTAL
Intervention: Divalproex
Number of subjects: 85

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 85
Study: 17011849

Group type: EXPERIMENTAL
Intervention: Dynamic contour tonometry PASCAL (DCT‐PASCAL)
Number of subjects: 107

Group type: COMPARATOR
Intervention: Goldmann applanation tonometry (GAT)
Number of subjects: 107
Study: 15058555

Group type: EXPERIMENTAL
Intervention: Ice application
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (no ice application)
Number of subjects: 36
Study: 11034230

Group type: EXPERIMENTAL
Intervention: Rehabilitation in a simulated environment (Easy Street) for 16 weeks
Number of subjects: 88

Group type: COMPARATOR
Intervention: Rehabilitation in a gymnasium setting for 16 weeks
Number of subjects: 88